Latest Biostrophin Stories
-Italian Medicines Agency (AIFA) approves cohort early access program - SOUTH PLAINFIELD, N.J., Nov. 3, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Data Supports Benefit in Nonsense Mutation Duchenne Muscular Dystrophy Patients SOUTH PLAINFIELD, N.J., Oct. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
-Top-line data expected H2 2015- SOUTH PLAINFIELD, N.J., Sept. 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Bill will help ensure law focuses adequately on needs of adults with Duchenne and other forms of muscular dystrophy WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- The House of
-French ATU Cohort and Other Named Patient Programs Authorized - SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
HACKENSACK, N.J., June 9, 2014 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy
Children with Duchenne muscular dystrophy often die as young adults from heart and breathing complications.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
- The parings of haberdine; also, any kind of fragments.